Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Neoplasms 3Leiomyoma 2Vomiting 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Periampullary Carcinoma Nos 1Pediatric Crohn's disease 1Pain 1Obesity 1Nausea 1Myasthenia Gravis 1Motor Activity 1Menstruation Disturbances 1Memory Disorders 1Hyperinsulinism 1Hyperandrogenism 1Hot Flashes 1Fatigue 1Cognitive Dysfunction 1Cancer Pain 1Anemia 1

Interventions

Gabapentin 3liposomal amphotericin B 2oxybutynin 1fezolinetant 1black cohosh root extract 1Venlafaxine Hydrochloride 1Vancomycin 1Testosterone 1Tazobactam 1Tamoxifen 1Tablets 1Sugars 1Soybean Proteins 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Levofloxacin 1Isoflavones 1Hypnosis 1Goserelin 1Folic Acid 1Filgrastim 1Estrogens, Conjugated (USP) 1Estradiol 1Cyproterone Acetate 1Citalopram 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hot Flashes × Sugars × Clear all
NCT00354432 2021-09-28

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

Wake Forest University Health Sciences

Phase 3 Terminated
120 enrolled 11 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡